IMR 5.41% 78.0¢ imricor medical systems inc.

News: IMR Imricor Medical Systems Says Visabl-Afl Trial For US FDA Approval Receives Ethics...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    March 11 (Reuters) - Imricor Medical Systems (IMR) :

    • VISABL-AFL TRIAL FOR US FDA APPROVAL RECEIVES ETHICS APPROVAL AT CARDIOVASCULAR INSTITUTE OF SOUTH PARIS

    (([email protected];))

 
watchlist Created with Sketch. Add IMR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.